Fernandez-Garcia L, Kirigo J, Huelgas-Mendez D, Benedik M, Tomas M, Garcia-Contreras R
Microb Biotechnol. 2024; 17(8):e14543.
PMID: 39096350
PMC: 11297538.
DOI: 10.1111/1751-7915.14543.
Perlemoine P, Marcoux P, Picard E, Hadji E, Zelsmann M, Mugnier G
PLoS One. 2021; 16(3):e0248917.
PMID: 33755710
PMC: 7987195.
DOI: 10.1371/journal.pone.0248917.
Zhao F, Sun H, Zhou X, Liu G, Li M, Wang C
Virus Genes. 2019; 55(4):532-540.
PMID: 31004278
DOI: 10.1007/s11262-019-01664-0.
Parkins M, Somayaji R, Waters V
Clin Microbiol Rev. 2018; 31(4).
PMID: 30158299
PMC: 6148191.
DOI: 10.1128/CMR.00019-18.
Xu Y, Yu X, Gu Y, Huang X, Liu G, Liu X
Front Microbiol. 2018; 9:793.
PMID: 29780362
PMC: 5945888.
DOI: 10.3389/fmicb.2018.00793.
Rapid identification and antibiotic resistance determination by bacteriophage amplification and MALDI-TOF MS.
Cox C, Saichek N, Schweizer H, Voorhees K
Bacteriophage. 2014; 4:e29011.
PMID: 25050191
PMC: 4090906.
DOI: 10.4161/bact.29011.
Rapid identification of international multidrug-resistant Pseudomonas aeruginosa clones by multiple-locus variable number of tandem repeats analysis and investigation of their susceptibility to lytic bacteriophages.
Larche J, Pouillot F, Essoh C, Libisch B, Straut M, Lee J
Antimicrob Agents Chemother. 2012; 56(12):6175-80.
PMID: 22985882
PMC: 3497159.
DOI: 10.1128/AAC.01233-12.
Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15.
Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P
Antimicrob Agents Chemother. 2012; 56(7):3568-75.
PMID: 22491690
PMC: 3393425.
DOI: 10.1128/AAC.06330-11.
PROPERTIES OF PSEUDOMONAS AERUGINOSA EXHIBITING SELF-LYSIS.
Berk R, GRONKOWSKI L
Antonie Van Leeuwenhoek. 1964; 30:141-53.
PMID: 14195244
DOI: 10.1007/BF02046720.
PYOCINE-TYPING OF HOSPITAL STRAINS OF PSEUDOMONAS PYOCYANEA.
DARRELL J, WAHBA A
J Clin Pathol. 1964; 17:236-42.
PMID: 14159450
PMC: 480731.
DOI: 10.1136/jcp.17.3.236.
ISOLATION AND PRELIMINARY CHARACTERISTICS OF THREE BACTERIOPHAGES ASSOCIATED WITH A LYSOGENIC STRAIN OF PSEUDOMONAS AERUGINOSA.
Feary T, FISHER Jr E, FISHER T
J Bacteriol. 1964; 87:196-208.
PMID: 14102854
PMC: 276979.
DOI: 10.1128/jb.87.1.196-208.1964.
SEMISYNTHETIC MEDIUM FOR BACTERIOPHAGE TYPING OF PSEUDOMONAS.
Sutter V, HURST V, Fennell J
J Bacteriol. 1963; 86:1354-6.
PMID: 14086120
PMC: 283660.
DOI: 10.1128/jb.86.6.1354-1356.1963.
Serological group differentiation of Pseudomonas aeruginosa from various sources.
Thorne H, Kyrkjebo A
Acta Vet Scand. 1966; 7(4):289-95.
PMID: 4960200
PMC: 8823331.
Dissociation in Pseudomonas aeruginosa.
Zierdt C, Schmidt P
J Bacteriol. 1964; 87(5):1003-10.
PMID: 4959790
PMC: 277138.
DOI: 10.1128/jb.87.5.1003-1010.1964.
Epidemiology of pseudomonas aeruginosa in a burn hospital: evaluation of serological, bacteriophage, and pyocin typing methods.
Edmonds P, SUSKIND R, MacMILLAN B, Holder I
Appl Microbiol. 1972; 24(2):213-8.
PMID: 4627229
PMC: 380584.
DOI: 10.1128/am.24.2.213-218.1972.
Susceptibility of recent isolates of Pseudomonas aeruginosa to gentamicin, polymyxin, and five penicillins, with observations on the pyocin and immunotypes of the strains.
Adler J, FINLAND M
Appl Microbiol. 1971; 22(5):870-5.
PMID: 4332044
PMC: 376437.
DOI: 10.1128/am.22.5.870-875.1971.
Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.
Brokopp C, Gomez-Lus R, Farmer 3rd J
J Clin Microbiol. 1977; 5(6):640-9.
PMID: 407246
PMC: 274671.
DOI: 10.1128/jcm.5.6.640-649.1977.